200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 61837-65-8
61837-65-8 | 2,4-Imidazolidinedione, 5-ethyl-5-(4-hydroxyphenyl)-3-methyl-
CAS No: 61837-65-8 Catalog No: AG00IAXC MDL No:
Product Description
Catalog Number:
AG00IAXC
Chemical Name:
2,4-Imidazolidinedione, 5-ethyl-5-(4-hydroxyphenyl)-3-methyl-
CAS Number:
61837-65-8
Molecular Formula:
C12H14N2O3
Molecular Weight:
234.2512
IUPAC Name:
5-ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione
InChI:
InChI=1S/C12H14N2O3/c1-3-12(8-4-6-9(15)7-5-8)10(16)14(2)11(17)13-12/h4-7,15H,3H2,1-2H3,(H,13,17)
InChI Key:
OQPLORUDZLXXPD-UHFFFAOYSA-N
SMILES:
CCC1(NC(=O)N(C1=O)C)c1ccc(cc1)O
Properties
Complexity:
337
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
234.1g/mol
Formal Charge:
0
Heavy Atom Count:
17
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
234.255g/mol
Monoisotopic Mass:
234.1g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
69.6A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2
Literature
| Title | Journal |
|---|---|
| Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. | PloS one 20140101 |
| Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system. | Toxicology in vitro : an international journal published in association with BIBRA 20130901 |
| Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions. | Journal of applied toxicology : JAT 20130201 |
| Liver disease selectively modulates cytochrome P450--mediated metabolism. | Clinical pharmacology and therapeutics 20060901 |
| Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20060101 |
| The influence of St John's Wort on CYP2C19 activity with respect to genotype. | Journal of clinical pharmacology 20040601 |
| Validated assays for human cytochrome P450 activities. | Drug metabolism and disposition: the biological fate of chemicals 20040601 |
| Quantification of mephenytoin and its metabolites 4'-hydroxymephenytoin and nirvanol in human urine using a simple sample processing method. | Rapid communications in mass spectrometry : RCM 20040101 |
| Simultaneous enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma by liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705 |
| Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19. | Drug metabolism and disposition: the biological fate of chemicals 20030501 |
| Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects. | Clinical pharmacology and therapeutics 20030301 |
| mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. | Xenobiotica; the fate of foreign compounds in biological systems 20030301 |
| Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19. | Epilepsy research 20021201 |
| Monolithic silica rod liquid chromatography with ultraviolet or fluorescence detection for metabolite analysis of cytochrome P450 marker reactions. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125 |
| Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. | Journal of cardiac failure 20021001 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.